Inactive Instrument
Probi AB Share Price
Stocks
PROB
SE0001280355
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 08/12/2022 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 01/08/2025 |
James Henson
COO | Chief Operating Officer | 39 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 01/01/2014 |
| Chairman | 62 | 01/04/2015 | |
| Director/Board Member | 64 | 04/05/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/02/25 | Buy | Company | 1,42,586 | 1.2514% | ||
| 21/01/25 | Buy | Company | 28,40,101 | 24.9260% | ||
| 28/11/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.29% | - | - | 3.37Cr | |
| +0.34% | +5.47% | +60.77% | +169.84% | 1,08900Cr | |
| +0.43% | +4.63% | +59.10% | +59.65% | 64TCr | |
| +0.91% | +5.09% | +39.21% | +77.96% | 47TCr | |
| -0.67% | +9.84% | +40.69% | +34.92% | 36TCr | |
| -0.32% | +3.77% | +37.31% | +42.81% | 30TCr | |
| +1.67% | +3.20% | +17.48% | +17.18% | 27TCr | |
| +0.63% | +5.07% | -3.23% | -38.53% | 23TCr | |
| +0.69% | +8.24% | +30.53% | +69.22% | 21TCr | |
| -0.25% | +2.25% | +16.67% | +75.03% | 17TCr | |
| Average | +0.29% | +5.07% | +33.17% | +56.46% | 41.46TCr | |
| Weighted average by Cap. | +0.32% | +5.14% | +43.29% | +82.57% |
Employees
-
Sector
Pharmaceuticals
